Skip to content

Clinical Application Value of 99mTc-FAPI SPECT/CT in Ovarian Cancer

Clinical Application Value of 99mTc-FAPI SPECT/CT in Ovarian Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108813
Enrollment
Unknown
Registered
2025-09-05
Start date
2024-06-21
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Interventions

Index test:99mTc-FAPI SPECT/CT

Sponsors

Fuzhou University Affiliated Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years; 2. Newly diagnosed, treatment-naive patients with suspected or confirmed ovarian cancer; 3. Patients with previously confirmed ovarian cancer who achieved clinical complete remission but are suspected of recurrence; 4. Completion of both 99mTc-FAPI SPECT/CT and 18F-FDG PET/CT or contrast-enhanced CT at our institution within 14 days; 5. Willingness to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Newly diagnosed patients without histopathological confirmation; 2. Suspected recurrent patients lacking histopathological confirmation and unavailable for follow-up; 3. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
99mTc-FAPI SPECT/CT related parameters;Sensitivity;Specificity;Accuracy;Positive predictive value;Negative predictive value;

Secondary

MeasureTime frame
Peritoneal Cancer Index;

Countries

China

Contacts

Public ContactShen Minghong

Fuzhou University Affiliated Provincial Hospital

fjslyyshenmh@163.com+86 153 0602 7674

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026